Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498899 | SCV000590656 | uncertain significance | not provided | 2017-06-21 | criteria provided, single submitter | clinical testing | The T91M variant in the IL2RA gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The T91M variant is observed in 53/6,604 (0.8%) alleles from individuals of Finnish background and 147/66,618 (0.2%) alleles from individuals of European (non-Finnish) background in the ExAC dataset (Lek et al., 2016). The T91M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret T91M as a variant of uncertain significance. |
Labcorp Genetics |
RCV001083317 | SCV000641195 | benign | Immunodeficiency due to CD25 deficiency | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001083317 | SCV001263551 | likely benign | Immunodeficiency due to CD25 deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ce |
RCV000498899 | SCV001745994 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925437 | SCV004738373 | likely benign | IL2RA-related disorder | 2022-11-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |